News & AnalysisSense Biodetection rakes in $65m Series BSense Biodetection, a global molecular diagnostics firm, has raised $65 million in Series B funding.ByIris Dorbian17 November 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs